Generate a tailored SOP for Dr. Rashmi Bhakuni. Improve your application with a focused, well-structured draft.
Rashmi Bhakuni, PhD, is an Acting Instructor and translational scientist at the University of Washington's Department of Dermatology. She has made significant contributions as a Postdoctoral Scholar in the Nghiem Lab, focusing her research on Merkel cell carcinoma, a rare and aggressive type of skin cancer. In her role, Dr. Bhakuni leads translational studies on targeted ATR inhibition in Merkel cell carcinoma, oversees multi-institutional NCI-sponsored MATRIX trials as a principal investigator, and is involved in grant writing for additional funding opportunities. Dr. Bhakuni completed her PhD in Biological Engineering at the Indian Institute of Technology in 2019, where her thesis focused on the molecular mechanisms related to ATR and NFBD1 as therapeutic targets in cancer. She has also earned a Master of Science in Microbiology from Kumaun University in 2012 and a Bachelor of Science in Life Sciences from the University of Delhi in 2010. Originally from New Delhi, India, Dr. Bhakuni's work is propelled by her mentor, Dr. Nghiem, and she continues to make impactful advances in the study of relevant molecular mechanisms to benefit patients with advanced Merkel cell carcinoma.
Department of Dermatology, University of Washington • Seattle, WA
Leading translational studies on targeted ATR inhibition in Merkel cell carcinoma.
Nghiem Lab, University of Washington • Seattle, WA
Focused on the study of Merkel cell carcinoma and trial design.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.